Ayman Allian, PhD

Ayman is a Principle Scientist at Amgen. He is currently leading Amgen’s central hazard evaluation lab and Amgen’s GMP scale up facilities located in California and Massachusetts. Ayman experience include supporting technical transfer from lab to internal scale up lab facilities and other facilities abroad such as Italy, Switzerland, Ireland and South Korea. Ayman interest in continuous manufacturing started about a decade ago when he developed and executed Abbott’s first continuous Ozonolysis reaction. Ayman grew up in Jerusalem, after he obtained a bachelor and MS in chemical engineering at the university of Illinois at Urbana Champaign, he went on to do his PHD in Singapore at NUS. After a post doctorate in Berkeley, 2008, he started his industrial career.